Agenda | CPhI Japan

English seminars or seminars with English interpretation

Keynote Seminar


Dr. Makoto Shiragami,
Proffesor, Department of Pharmaceutical Sciences,
Teikyo Heisei University

K-6: Pricing system reform in 2018 and introduction of cost-effectiveness assessment

Thursday April 19th | 09:30 - 10:45

【Language: English/Japanese】Free of Charge

Drastic reform of NHI drug price system was carried out recently from the viewpoint of achieving both "sustainability of national public insurance" and "promotion of innovation". In addition, a cost-effectiveness assessment was introduced, and as a first step, price adjustments were made for the items subject to trial implementation. I will explain these outlines and forecast future developments.

Special Seminar


Mr. Noriatsu Kono,
Managing Director,
Department of Innovative Drug Discovery and Development,
Japan Agency for Medical Research and Development (AMED)

K-7: AMED activities for innovative drug discovery in Japan

Thursday April 19th | 11:15 - 12:15

【Language: English/Japanese】Free of Charge

AMED was established in April 2015, consideration with providing a single window of support and funding for medical research and development (R&D) in line with government policy.  In this session I will try to introduce AMED challenges for innovative drug discovery and the R&D circumstance in Japan.

Drug Delivery System & Drug Packaging Technology Seminar


Dr. Theresa Bankston,
Director, Technical Services, BD Medical – Pharmaceutical Systems,
Becton Dickinson Co. Ltd.

D-4: Considerations for Selecting Drug Delivery Systems

Wednesday April 18th: 15:00 - 16:00

【Language: English/Japanese】 Free of Charge

The requirements for biologic drug approval continue to grow, with an overall aim to improve patient safety, experience and health outcomes while managing cost. With increased competition, defining drug development strategies which properly consider the delivery system is critical to a program’s success.
This session will cover technical considerations and testing strategies to optimize the selection of delivery systems and prove their suitability, compatibility, and performance with the drug as a combination product.

BioPharma Seminar


Ms. Fionn Huang,
Enterprise Sales Manager, APAC,
Finesse, a part of Thermofisher Scientific,
Thermo Fisher Scientific Inc.

L-4: The SMART Factory: end-to-end, modular automation for multiple processing platforms

Wednesday April 18th | 14:00 - 14:45

【Language: English/Japanese】 Free of Charge

As the challenges in biologics and vaccine manufacturing increase with fewer blockbuster drugs, emerging markets, patent expiration, shorter time-to-market, price pressures, and increased regulatory complexity, companies are turning to multi-product single-use facilities that can provide higher yield production with fewer employees and lesser capital cost.
SmartFactory is an operations management solution for single-use facilities that optimizes plant-wide resource utilization, integrates manufacturing (batch) information, and facilitates training and validation record management. SmartFactory has been optimized to increase productivity and maximize asset utilization, while retaining an open architecture. Bio-production process flows can be designed in a modular and scalable manner, using best-of-breed equipment (including Finesse SmartSystems), without compromising quality or compliance.

International Seminar - Taiwan

Speaker 1:
Ms. Ming-Ying Yu,
Associate Technical Specialist,
Consumer Goods & Chemical Industries Division,
Industrial Development Bureau , MOEA, Taiwan

Speaker 2:
Mr. Yukihiko Okamoto,
Sr. Project Manager,
Department of Industrial Services,
Medical and Pharmaceutical Industry Technology and Development Center, Taiwan

N-1: Business collaboration and investment opportunity in biotechnology and pharmaceutical industry between Japan and Taiwan & Introduce Taiwan pharmaceutical alliance website

Wednesday April 18th | 14:30 - 16:00

【Language: English/Japanese】 Free of Charge